ENTRY       D11234                      Drug
NAME        Emactuzumab (USAN/INN)
FORMULA     C6398H9908N1704O2020S44
EXACT_MASS  144339.2672
MOL_WEIGHT  144428.1929
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGASVKV SCKASGYTFT SYDISWVRQA PGQGLEWMGV IWTDGGTNYA
            QKLQGRVTMT TDTSTSTAYM ELRSLRSDDT AVYYCARDQR LYFDVWGQGT TVTVSSASTK
            GPSVFPLAPS SKSTSGGTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS
            LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DKKVEPKSCD KTHTCPPCPA PELLGGPSVF
            LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVKFNWYVDG VEVHNAKTKP REEQYNSTYR
            VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG QPREPQVYTL PPSRDELTKN
            QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD GSFFLYSKLT VDKSRWQQGN
            VFSCSVMHEA LHNHYTQKSL SLSPGK
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCRASEDVN TYVSWYQQKP GKAPKLLIYA ASNRYTGVPS
            RFSGSGSGTD FTLTISSLQP EDFATYYCQQ SFSYPTFGQG TKLEIKRTVA APSVFIFPPS
            DEQLKSGTAS VVCLLNNFYP REAKVQWKVD NALQSGNSQE SVTEQDSKDS TYSLSSTLTL
            SKADYEKHKV YACEVTHQGL SSPVTKSFNR GEC
            (Disulfide bridge: H22-H95, H143-H19, H219-L213, H225-H'225, H228-H'228, H260-H320, H366-H424, H'22-H'95, H'143-H'199, H'219-L'213, H'260-H'320, H'366-H'424, L23-L88, L133-L193, L'23-L'88, L'133-L'193)
  TYPE      Peptide
EFFICACY    Antineoplastic
  TYPE      Monoclonal antibody
TARGET      CSF1R (FMS, CD115) [HSA:1436] [KO:K05090]
  PATHWAY   hsa04060(1436)  Cytokine-cytokine receptor interaction
            hsa04380(1436)  Osteoclast differentiation
            hsa05200(1436)  Pathways in cancer
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               CSF and other factor receptors
                CSF1R (FMS, CD115)
                 D11234  Emactuzumab (USAN/INN)
DBLINKS     CAS: 1448221-67-7
            PubChem: 384585212
///
